Biotech stocks posted losses for the third straight week, as the sector reacted to broader market weakness and announcements out of the 2022 JPMorgan Healthcare conference. Here are the key catalysts that could move stocks in the unfolding week.

The Dow and S&P 500 are eyeing fourth-straight wins.

The S&P 500 and Nasdaq, meanwhile, are just above breakeven.